Navigation Links
Clinical Data on Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, to be Presented at the 2009 ASCO Meeting
Date:5/19/2009

ifferentiation, proliferation and survival/apoptosis. Dysregulation of the PI3 kinase signaling cascades can lead to cancer and aberrant PI3K pathway activity is observed with high frequency in a variety of tumor types. PI3K signaling through its downstream effectors AKT and mTOR is also known to promote tumor cell survival, proliferation, and growth. Notably, dysregulation of PI3K signaling is thought to contribute to resistance to a variety of anticancer therapies. Thus, PI3K is considered a high value target in treating cancer.

About Semafore Pharmaceuticals, Inc.

Semafore is a clinical stage drug discovery and development company focused on small molecule modulators of the PI3 kinase and PTEN cell signaling pathway, a promising target pathway for multiple disorders, including the company's focus - cancer. Semafore is a leader in the development of PI3K inhibitors and one of the first biopharmaceutical companies to focus on both PI3K and PTEN inhibitors. The Company has successfully discovered and is developing a portfolio of drug candidates addressing these targets. Semafore is also leveraging its experience in the PI3K arena to identify and design inhibitors that block multiple pathways. For more information see the company's web site at www.SemaforePharma.com.


'/>"/>
SOURCE Semafore Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data
2. U.S. Naval Medical Research Center Proposed RESUS Clinical Trial in Trauma Patients Remains on FDA Hold
3. Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
4. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
5. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
6. Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting
7. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
8. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
9. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
10. New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy
11. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... GARDEN CITY, England and ... Therapeutics, the leading GPCR drug discovery and development company, is pleased ... as a Consultant to augment the Company,s business development ... Mr Usui has more than 15 years of experience ... including senior roles at Perlegen Sciences, Inc., Roche Pharma ( ...
(Date:5/23/2013)... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... and Chief Executive Officer of Neurocrine Biosciences, will be presenting ... Care Conference in Boston.   The live presentation ... Time / 8:20 a.m. Pacific Time.  The presentation will be ... http://www.neurocrine.com . If you are unable ...
(Date:5/23/2013)... , May 23, 2013 Hearing health affects ... feel younger, and remain socially and professionally engaged, he should ... the overriding message that the Better Hearing Institute ... of National Men,s Health Week , which leads up ... Week runs from June 10 through June 16. ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4
... YORK, April 21, 2011 Reportlinker.com announces that ... its catalogue: Medical Equipment Monthly ... 2011 http://www.reportlinker.com/p0484491/Medical-Equipment-Monthly-Deals-Analysis---MA-and-Investment-Trends-April-2011.html ... and Investment Trends, April 2011 ...
... Reportlinker.com announces that a new market research report ... DrugFutures http://www.reportlinker.com/p0484753/Ophthalmology-DrugFutures ... Ophthalmology Drugs packed with facts, figures and forecasts for ... global ophthalmology sector faces both commercial challenge and clinical ...
Cached Medicine Technology:Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011 2Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011 3Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011 4Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011 5Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011 6Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011 7Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011 8Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011 9Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011 10Reportlinker Adds Ophthalmology DrugFutures 2Reportlinker Adds Ophthalmology DrugFutures 3Reportlinker Adds Ophthalmology DrugFutures 4Reportlinker Adds Ophthalmology DrugFutures 5Reportlinker Adds Ophthalmology DrugFutures 6Reportlinker Adds Ophthalmology DrugFutures 7Reportlinker Adds Ophthalmology DrugFutures 8Reportlinker Adds Ophthalmology DrugFutures 9
(Date:5/23/2013)... Vegas Hotel Escapes, the premier ... all new vacation packages for the upcoming memorial ... Vegas for this patriotic holiday will be pleased ... VegasHotelEscapes.com's new special pricing available on VegasHotelEscapes.com's website. ... guarantees the lowest prices possible on vacation packages ...
(Date:5/23/2013)... May 23, 2013 If you are ... irritable bowel syndrome (IBS), the food spread this Memorial ... fun. , “While hot dogs and ice cream have ... warm weather months, IBS sufferers often feel the painful ... MD, a gastroenterologist with Lourdes Medical Associates. , IBS ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Onlinefitnessreview.com recently ... Blast Diet to determine what makes this diet work ... published review highlights three main components of the program: ... a positive mindset and the personal motivation that is ... every 7 days to keep the metabolism rate in ...
(Date:5/23/2013)... By Denise Mann HealthDay Reporter , , THURSDAY, ... of Americans take to help treat hip and knee ... increase risk for developing glaucoma, a small new study ... there is an increase of intraocular pressure (IOP) or ... of the leading causes of blindness. ...
(Date:5/23/2013)... Plano, TX (PRWEB) May 23, 2013 ... the Marketplace , Chaplains have been a part of ... this Memorial Day, like those preceding it, these men ... service to the United States of America. As ... trend of their migration to the workplace chaplaincy world. ...
Breaking Medicine News(10 mins):Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3Health News:Onlinefitnessreview.com Publishes 7 Day Belly Blast Diet Review 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3
... at the NCCN 14th Annual Conference, presented various views on ... experts tackled the spectrum of issues related to defining value, ... of the latest cancer treatments may not warrant their costs. ... rapid growth, both in terms of technological innovation and costs ...
... A small number of products contain allergens no matter what ... News) -- A small number of food products with a ... while about 2 percent of foods products without such a ... offending products more often came from smaller companies, noted the ...
... Fitness Industry Leader Introduces Commercial Grade Cardio Bike ... March 16 Expresso Fitness(R), the leading supplier ... announced the launch of the S3 Upright Youth ... children ages 9-14. The S3 Youth Bike ...
... WASHINGTON, March 16 The African American Health Alliance (AAHA) is ... because of actions by President Barack Obama. In less than two ... improve the health of the American people. His --, ... the Children,s Health Insurance Program Act (CHIP) ensures that more children ...
... day resolution in 2009? Join media mogul Sally Jessy Raphael ... Beres as they take listeners on a journey of seeing ... When you set out to work on your Earth ... upstairs closet, digging through an avalanche of junk should not ...
... STXS ) today announced that it has extended ... of SVB Financial Group (Nasdaq: SIVB ). ... the Company can borrow up to $25 million. "This ... cash position and other financing sources, provides us with the ...
Cached Medicine News:Health News:Experts Weigh in on Controversial Issue of Determining Value of Cancer Care at NCCN Conference 2Health News:Experts Weigh in on Controversial Issue of Determining Value of Cancer Care at NCCN Conference 3Health News:Experts Weigh in on Controversial Issue of Determining Value of Cancer Care at NCCN Conference 4Health News:Experts Weigh in on Controversial Issue of Determining Value of Cancer Care at NCCN Conference 5Health News:Food Allergy Labeling Not Always Accurate 2Health News:Food Allergy Labeling Not Always Accurate 3Health News:Expresso Fitness(R) Launches First Virtual Reality Cardio Bike for Kids 2Health News:African American Health Alliance: On The Road to Health Reform 2Health News:Sally Jessy Raphael Bids Farewell to Her Infamous Red Glasses, Reports Green Nest 2Health News:Stereotaxis Extends Its Credit Facility With Silicon Valley Bank 2Health News:Stereotaxis Extends Its Credit Facility With Silicon Valley Bank 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: